EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2023 • Dominari Holdings Inc. • Pharmaceutical preparations
Contract Type FiledMay 5th, 2023 Company IndustryTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered effective as of May 1, 2023 (the “Effective Date”), by and between Dominari Holdings, Inc., a Delaware corporation with offices at 725 5th Avenue, New York, NY 10022 (the “Corporation”), and Matthew B. McCullough, an individual residing in the State of New York (the “Executive”), under the following circumstances:
EMPLOYMENT AGREEMENTEmployment Agreement • April 3rd, 2023 • Dominari Holdings Inc. • Pharmaceutical preparations
Contract Type FiledApril 3rd, 2023 Company IndustryTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into on March 29, 2023, by and between Dominari Holdings, Inc., a Delaware corporation with offices at 725 5th Avenue, New York, NY 10022 (the “Corporation”), and George M. Way, an individual residing 156 Firethorne Trail, Basking Ridge, NJ 07920-3176 (the “Executive”), under the following circumstances:
EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2023 • Dominari Holdings Inc. • Pharmaceutical preparations
Contract Type FiledMarch 31st, 2023 Company IndustryTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered effective as of July 22, 2022 (the “Effective Date”), by and between Aikido Pharma Inc., a Delaware with offices at One Rockefeller Plaza, 11th Floor, New York, NY (the “Corporation”), and Carlos Aldavero, an individual residing at 5 West 86th Street, Apt. 9E, New York, NY 10024 (the “Executive”), under the following circumstances:
EMPLOYMENT AGREEMENTEmployment Agreement • January 6th, 2023 • Dominari Holdings Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 6th, 2023 Company IndustryTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of July 1, 2022 (the “Effective Date”), by and between AIKIDO PHARMA, INC. a Delaware corporation with offices at One Rockefeller Plaza, 11th Floor, New York, NY 10020 (the “Corporation”), and Chris Devall, an individual residing at 1920 Long Bridge Lane, Virginia Beach, VA 23454 (the “Executive”), under the following circumstances: